NCT00094406View on ClinicalTrials.gov

Carbon Monoxide to Prevent Lung Inflammation

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 13, 2004

Primary Completion Date

March 11, 2010

Study Completion Date

March 11, 2010

Conditions
Respiratory Distress Syndrome, Adult
Interventions
PROCEDURE

Bronchoscopy

PROCEDURE

Bronchoalveolar lavage

DRUG

Endotoxin

DRUG

Carbon Monoxide

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00094406 - Carbon Monoxide to Prevent Lung Inflammation | Biotech Hunter | Biotech Hunter